Home » Mtaz Tablets 30mg
Cell Laboratories

Mtaz Tablets 30mg

In stock
(0)
Rs.1,000.00 PKR inc. VAT

You can promote by sharing on social networks on the links.

Product Description

Product Name: Mtaz Tablets 30mg

Product Form: Tablets

Pack Size: 20's

Manufactured By: Cell Laboratories

Used For:

  1. Major Depressive Disorder (MDD):
    • Primarily used to treat depression by improving mood, sleep, and appetite.
  2. Anxiety Disorders (Off-Label Use):
    • Used in generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder.
  3. Insomnia (Off-Label Use):
    • Helps improve sleep due to its sedative effects.
  4. Appetite Stimulation:
    • Often prescribed for patients with depression who experience significant weight loss or poor appetite.
  5. Post-Traumatic Stress Disorder (PTSD) (Off-Label Use).
  6. Neuropathic Pain (Off-Label Use):
    • Occasionally used to manage chronic pain conditions.
Side Effects:

  • Common Side Effects:

    • Sedation or drowsiness (more pronounced at lower doses).
    • Increased appetite and weight gain.
    • Dry mouth.
    • Constipation.
    • Dizziness.

  • Less Common Side Effects:

    • Restlessness or agitation.
    • Low blood pressure (orthostatic hypotension).
    • Strange dreams or vivid nightmares.
    • Swelling in extremities (edema).

  • Serious Side Effects (Seek Medical Attention):

    • Suicidal Thoughts: Particularly in younger patients.
    • Low Sodium Levels (Hyponatremia): Symptoms include confusion or seizures.
    • Neutropenia/Agranulocytosis: Rarely, it can suppress white blood cell production, increasing infection risk.
    • Serotonin Syndrome: If used with other serotonergic drugs.
Precautions:

  1. Medical History:

    • Inform your doctor if you have:
      • Bipolar disorder (risk of manic episodes).
      • Liver or kidney disease (may require dosage adjustments).
      • Seizures or epilepsy.
      • Glaucoma.
    • Avoid in patients with a known hypersensitivity to Mirtazapine.

  2. Drug Interactions:

    • Avoid combining with MAO inhibitors (e.g., phenelzine, tranylcypromine).
    • Caution with other CNS depressants (e.g., alcohol, benzodiazepines).
    • Risk of serotonin syndrome when combined with SSRIs, SNRIs, or other serotonergic drugs.

  3. Pregnancy and Breastfeeding:

    • Use only if benefits outweigh risks; safety during pregnancy is not well-established.
    • Excreted in breast milk, so caution is advised.

  4. Driving and Operating Machinery:

    • May cause drowsiness or impair judgment, especially at the start of treatment.

  5. Monitoring:

    • Regular follow-ups to assess response and side effects.
    • Monitor for worsening depression or suicidal ideation, particularly in the first few weeks of treatment.